1-9 of 9
Shuangyou Liu
Close
Sort by
Journal Articles

T Cell Selection Is Not Helpful for Therapeutic Efficacy of CART19 in Relapsed or Refractory B-ALL Patients with Peripheral Blood Leukemia Burden at Time of Apheresis

Biping Deng, Zhaoli Liu, Jing PAN, Shuangyou Liu, Xiaoming Qu, Yu'e Zhang, Lingli Zhang, Ming Ma, Zhongxin Zhang, Xinjian Yu, Qinlong Zheng, Chunrong Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 6943.
https://doi.org/10.1182/blood-2023-180359
Published: 2023
Journal Articles

CD58 Could be As a Leukemic Marker in Relapsed/Refractory B-ALL Patients after Multiline Therapies

Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Yafeng Li, Xichang Zheng, Tong Wu, Shuangyou Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 1043–1044.
https://doi.org/10.1182/blood-2022-164946
Published: 2022
Journal Articles

The Quick Antigen Identification By Tissue Flow Cytometry for CAR-T Therapy in Relapsed/Refractory B-Cell Malignancies without Bone Marrow Involvement or Serous Cavity Effusions

Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Xichang Zheng, Yunmei Zhang, Wenhong Yang, Tong Wu, MD, Shuangyou Liu
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-139437
Published: 2020
Journal Articles

CD22 Gating for Flow Cytometric Analysis in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia after CD19 CAR-T Therapy

Xinjian Yu, Pan Li, Heyuan Feng, Jian Kang, Xichang Zheng, Yunmei Zhang, Wenhong Yang, Tong Wu, MD, Shuangyou Liu
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-139341
Published: 2020
Journal Articles

Leukemia Burden in Peripheral Blood Has Negative Impact on CD19-CART Cell Culture and Its Clinical Efficacy in Patients with Refractory or Relapsed B Cell Acute Lymphoblastic Leukemia

Biping Deng, BS, MD, Jing Pan, Shuangyou Liu, Yuehui Lin, Zhaoli Liu, Yunlong Chen, Xiaoming Qu, Yu 'e Zhang, Zhongxin Zhang, Xuansha Niu, Ming Ma, Tong Wu, MD, Alex Hong Chang, Chunrong Tong
Journal: Blood
Blood (2019) 134 (Supplement_1): 1957.
https://doi.org/10.1182/blood-2019-126695
Published: 2019
Journal Articles

Corticosteroids Do Not Influence the Efficacy and Kinetics of CAR-T Cells for B-Cell Acute Lymphoblastic Leukemia

Shuangyou Liu, Biping Deng, BS, MD, Jing PAN, Zhichao Yin, Yuehui Lin, Zhuojun Ling, Tong Wu, MD, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong
Journal: Blood
Blood (2019) 134 (Supplement_1): 228.
https://doi.org/10.1182/blood-2019-123051
Published: 2019
Journal Articles

Sequential CD19- and CD22-CART Cell Therapies for Relapsed B-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Shuangyou Liu, Biping Deng, Yuehui Lin, Zhichao Yin, Jing Pan, Tong Wu, Zhiyong Gao, Yanzhi Song, Yongqiang Zhao, Chunrong Tong
Journal: Blood
Blood (2018) 132 (Supplement 1): 2126.
https://doi.org/10.1182/blood-2018-99-111856
Published: 2018
Journal Articles

NOTCH1 Transcriptionally Activates Deptor and Promotes AKT Activation in Acute T-Cell Lymphoblastic Leukemia

Hudan Liu, Yufeng Hu, Hexiu Su, Qi Ye, Zhaojing Wang, Liang Huang, Qian Wang, Suning Chen, Jianfeng Zhou, Shuangyou Liu, Guoliang Qing
Journal: Blood
Blood (2014) 124 (21): 895.
https://doi.org/10.1182/blood.V124.21.895.895
Published: 2014
Journal Articles

High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-β and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response

Marc Remke, Stefan Pfister, Corinne Kox, Grischa Toedt, Natalia Becker, Axel Benner, Wiebke Werft, Stephen Breit, Shuangyou Liu, Felix Engel, Andrea Wittmann, Martin Zimmermann, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Claus R. Bartram, Bernhard Radlwimmer, Martina U. Muckenthaler, Peter Lichter, Andreas E. Kulozik
Journal: Blood
Blood (2009) 114 (5): 1053–1062.
https://doi.org/10.1182/blood-2008-10-186536
Published: 2009
Includes: Supplemental data